FR21C1033I2 - Systeme d'administration de medicament comprenant un oestrogene tetrahydroxyle destine a une contraception hormonale - Google Patents
Systeme d'administration de medicament comprenant un oestrogene tetrahydroxyle destine a une contraception hormonaleInfo
- Publication number
- FR21C1033I2 FR21C1033I2 FR21C1033C FR21C1033C FR21C1033I2 FR 21C1033 I2 FR21C1033 I2 FR 21C1033I2 FR 21C1033 C FR21C1033 C FR 21C1033C FR 21C1033 C FR21C1033 C FR 21C1033C FR 21C1033 I2 FR21C1033 I2 FR 21C1033I2
- Authority
- FR
- France
- Prior art keywords
- tetrahydroxyl
- estrogen
- delivery system
- drug delivery
- hormonal contraception
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01201945A EP1293210B1 (en) | 2001-05-23 | 2001-05-23 | Means and method for hormonal contraception |
EP01201946 | 2001-05-23 | ||
EP01201947 | 2001-05-23 | ||
EP01204377 | 2001-11-15 | ||
EP02075695 | 2002-02-21 | ||
EP02738961A EP1390042B1 (en) | 2001-05-23 | 2002-05-23 | Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception |
PCT/NL2002/000331 WO2002094279A1 (en) | 2001-05-23 | 2002-05-23 | Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception |
Publications (2)
Publication Number | Publication Date |
---|---|
FR21C1033I1 FR21C1033I1 (fr) | 2021-10-15 |
FR21C1033I2 true FR21C1033I2 (fr) | 2022-04-22 |
Family
ID=27513107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR21C1033C Active FR21C1033I2 (fr) | 2001-05-23 | 2021-07-27 | Systeme d'administration de medicament comprenant un oestrogene tetrahydroxyle destine a une contraception hormonale |
Country Status (12)
Country | Link |
---|---|
US (1) | US7732430B2 (es) |
EP (1) | EP1390042B1 (es) |
CA (1) | CA2448278C (es) |
CY (1) | CY1108093T1 (es) |
DE (1) | DE60223795T2 (es) |
DK (1) | DK1390042T3 (es) |
ES (1) | ES2296943T3 (es) |
FR (1) | FR21C1033I2 (es) |
LU (1) | LUC00213I2 (es) |
NL (1) | NL301115I2 (es) |
PT (1) | PT1390042E (es) |
WO (1) | WO2002094279A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2503549C (en) | 2002-10-23 | 2012-07-10 | Pantarhei Bioscience B.V. | Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
EP1562976B1 (en) | 2002-11-08 | 2010-05-26 | Pantarhei Bioscience B.V. | Synthesis of estetrol via estrone derived steroids |
MX342537B (es) | 2011-06-01 | 2016-10-04 | Estetra Sprl | Proceso para la produccion de intermediarios de estetrol. |
MX341561B (es) | 2011-06-01 | 2016-08-25 | Estetra Sprl | Proceso para la produccion de intermediarios de estetrol. |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
US10179107B2 (en) | 2011-07-19 | 2019-01-15 | Pantarhei Bioscience B.V. | Tablet containing dehydroepiandrosterone (DHEA) |
EA028780B1 (ru) * | 2011-08-11 | 2017-12-29 | Эстетра С.П.Р.Л. | Применение эстетрола в качестве экстренного контрацептива |
WO2013034780A2 (en) | 2012-12-20 | 2013-03-14 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol and related compounds |
CA2924255C (en) | 2013-09-18 | 2022-11-22 | Crystal Pharma, S.A.U. | Process for the preparation of estetrol |
EP3079671B1 (en) * | 2013-12-12 | 2017-10-25 | Donesta Bioscience B.V. | Orally disintegrating solid dosage unit containing an estetrol component |
GEP20217243B (en) | 2015-06-18 | 2021-04-26 | Sprl Estetra | Orodispersible dosage unit containing an estetrol component |
HUE054551T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Ösztetrolt tartalmazó, szájban diszpergálódó tabletta |
NO3106148T3 (es) | 2015-06-18 | 2018-08-11 | ||
WO2016203009A1 (en) | 2015-06-18 | 2016-12-22 | Mithra Pharmaceuticals S.A. | Orodispersible tablet containing estetrol |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
UY38075A (es) * | 2018-02-07 | 2019-10-01 | Estetra Sprl | Composiciones anticonceptivas con efectos cardiovasculares reducidos |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
WO2023152682A1 (en) | 2022-02-10 | 2023-08-17 | Estetra Srl | Contraceptive methods with scheduled bleeding effects |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3440320A (en) | 1964-06-18 | 1969-04-22 | Mortimer D Sackler | Chelated suppository and method of using same |
US3797494A (en) | 1969-04-01 | 1974-03-19 | Alza Corp | Bandage for the administration of drug by controlled metering through microporous materials |
DE2426779A1 (de) | 1974-05-31 | 1975-12-18 | Schering Ag | 1.3-oxygenierte 8 alpha-oestratriene |
DE2336433A1 (de) | 1973-07-13 | 1975-04-03 | Schering Ag | 1.3-oxygenierte 8 alpha-oestratriene |
DE2336434A1 (de) | 1973-07-13 | 1975-04-17 | Schering Ag | 1.3-oxygenierte 8 alpha-oestratriene |
US4722941A (en) | 1978-06-07 | 1988-02-02 | Kali-Chemie Pharma Gmbh | Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof |
US4460372A (en) | 1981-02-17 | 1984-07-17 | Alza Corporation | Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer |
US4573996A (en) | 1984-01-03 | 1986-03-04 | Jonergin, Inc. | Device for the administration of an active agent to the skin or mucosa |
US4624665A (en) | 1984-10-01 | 1986-11-25 | Biotek, Inc. | Method of transdermal drug delivery |
US4937238A (en) | 1986-03-04 | 1990-06-26 | The Board Of Regents Of The University Of Nebraska | Prevention of mammary carcinoma |
US4762717A (en) | 1986-03-21 | 1988-08-09 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use as a contraceptive |
US5223261A (en) | 1988-02-26 | 1993-06-29 | Riker Laboratories, Inc. | Transdermal estradiol delivery system |
US5043331A (en) | 1989-06-15 | 1991-08-27 | Orion-Yhtyma Oy | Treatment of postmenopausal disorders |
US5130137A (en) | 1989-08-09 | 1992-07-14 | The General Hospital Corporation | Continuous delivery of luteinizing hormone releasing hormone compositions in combination with sex steroid delivery for use in treating benign ovarian secretory disorders |
JPH04235171A (ja) | 1990-07-26 | 1992-08-24 | Sumitomo Chem Co Ltd | スルホヒドロキサム酸誘導体、その製造法およびそれを有効成分とする除草剤 |
US5063507A (en) | 1990-09-14 | 1991-11-05 | Plains Cotton Cooperative Association | Goods database employing electronic title or documentary-type title |
US5340585A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Method and formulations for use in treating benign gynecological disorders |
US5340586A (en) | 1991-04-12 | 1994-08-23 | University Of Southern California | Methods and formulations for use in treating oophorectomized women |
US5211952A (en) * | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
US5468736A (en) | 1993-02-25 | 1995-11-21 | The Medical College Of Hampton Road | Hormone replacement therapy |
US5895783A (en) | 1993-07-16 | 1999-04-20 | Schering Aktiengesellschaft | Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
NL9301562A (nl) | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
DE4344405C2 (de) * | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
WO1996003929A1 (en) | 1994-08-04 | 1996-02-15 | Biex, Inc. | Method for prediction of premature delivery using estetrol (e4) as an indicator |
DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
ES2247710T3 (es) | 1997-06-20 | 2006-03-01 | Akzo Nobel N.V. | Antagonista de gonadotropina. |
DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
US6214815B1 (en) * | 1998-12-23 | 2001-04-10 | Ortho-Mcneil Pharmaceuticals, Inc. | Triphasic oral contraceptive |
DE19917930A1 (de) | 1999-04-15 | 2000-10-19 | Schering Ag | Ent-Steroide als selektiv wirksame Estrogene |
JP2003527310A (ja) | 1999-04-16 | 2003-09-16 | イエナフアルム ゲーエムベーハー ウント ツェーオー. カーゲー | エストロゲンを局部的に皮内投与するための医薬品組成物または化粧品組成物 |
US7273932B1 (en) | 1999-05-28 | 2007-09-25 | The University Of Cincinnati | Antisense oligonucleotides for fertility and menstrual cycle regulation and for chemopreventive and chemotherapeutic use |
WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
EP1286664B1 (en) | 2000-05-12 | 2007-07-25 | Oregon Health and Science University | Combination of low dose estrogen and immunotherapeutic agent for treating immune diseases |
US6936599B2 (en) | 2001-04-25 | 2005-08-30 | The Regents Of The University Of California | Estriol therapy for multiple sclerosis and other autoimmune diseases |
EP1260225A1 (en) | 2001-05-18 | 2002-11-27 | Pantarhei Bioscience B.V. | A pharmaceutical composition for use in hormone replacement therapy |
ES2278925T3 (es) * | 2001-11-15 | 2007-08-16 | Pantarhei Bioscience B.V. | Uso de compuestos estrogenicos en combinacion con compuestos progestogenicos en terapias de sustitucion hormonal. |
-
2002
- 2002-05-23 CA CA2448278A patent/CA2448278C/en not_active Expired - Lifetime
- 2002-05-23 EP EP02738961A patent/EP1390042B1/en not_active Expired - Lifetime
- 2002-05-23 DE DE60223795T patent/DE60223795T2/de not_active Expired - Lifetime
- 2002-05-23 DK DK02738961T patent/DK1390042T3/da active
- 2002-05-23 US US10/478,365 patent/US7732430B2/en active Active
- 2002-05-23 PT PT02738961T patent/PT1390042E/pt unknown
- 2002-05-23 WO PCT/NL2002/000331 patent/WO2002094279A1/en active IP Right Grant
- 2002-05-23 ES ES02738961T patent/ES2296943T3/es not_active Expired - Lifetime
-
2008
- 2008-02-04 CY CY20081100136T patent/CY1108093T1/el unknown
-
2021
- 2021-07-07 NL NL301115C patent/NL301115I2/nl unknown
- 2021-07-08 LU LUC00213 patent/LUC00213I2/en unknown
- 2021-07-27 FR FR21C1033C patent/FR21C1033I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
US7732430B2 (en) | 2010-06-08 |
DE60223795D1 (de) | 2008-01-10 |
DE60223795T2 (de) | 2008-11-27 |
EP1390042A1 (en) | 2004-02-25 |
US20040198710A1 (en) | 2004-10-07 |
DK1390042T3 (da) | 2008-03-31 |
NL301115I1 (es) | 2021-07-14 |
CA2448278A1 (en) | 2002-11-28 |
FR21C1033I1 (fr) | 2021-10-15 |
EP1390042B1 (en) | 2007-11-28 |
CA2448278C (en) | 2010-06-08 |
WO2002094279A1 (en) | 2002-11-28 |
CY1108093T1 (el) | 2014-02-12 |
PT1390042E (pt) | 2008-03-10 |
ES2296943T3 (es) | 2008-05-01 |
LUC00213I2 (es) | 2021-10-29 |
LUC00213I1 (es) | 2021-07-08 |
NL301115I2 (nl) | 2021-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR21C1033I2 (fr) | Systeme d'administration de medicament comprenant un oestrogene tetrahydroxyle destine a une contraception hormonale | |
FR2792842B1 (fr) | Systeme de delivrance de bolus de medicament | |
EP1091732A4 (en) | ORAL EFFERVESCENT MEDICATION DELIVERY SYSTEM | |
EP1416920A4 (en) | MULTIPLEXES, MEDICAL DISPENSING SYSTEM SUITABLE FOR ORAL ADMINISTRATION | |
AU7333601A (en) | Drug delivery management system | |
HUP0001914A3 (en) | Biocompatible compounds for pharmaceutical drug delivery systems | |
EP1150629A4 (en) | MEDICINAL DOSAGE UNIT FOR ORAL ADMINISTRATION OF ACTIVE STEROID AGENTS | |
HUP0401438A3 (en) | Drug delivery system | |
IL157771A (en) | Intra-vaginal devices for drug delivery for administration of a bactericidal agent | |
EP1239831A4 (en) | IMPROVED PHARMACEUTICAL COMPOSITIONS FOR HEAVY-DIFFERENT MEDICAMENTS | |
FR2795967B1 (fr) | Systeme de protection d'un dispositif implantable d'administration de medicament vis-a-vis d'un remplissage excessif | |
HK1034898A1 (en) | Topical compositions for nsai drug delivery. | |
GB0111762D0 (en) | Drug delivery mask for animals | |
HK1048428A1 (en) | Ophthalmic drug delivery device. | |
HUP0401281A3 (en) | Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals | |
NZ513700A (en) | Oral drug delivery system | |
NO20004196D0 (no) | Innretninger for legemiddelavlevering | |
HK1077523A1 (en) | Proliposomal drug delivery system | |
AU3787501A (en) | New self emulsifying drug delivery system | |
HRPK20010706B1 (en) | Tolperison-containing, pharmaceutical preparation for oral administration | |
EE05415B1 (et) | Ravimi manustamise vahend, eriti androgeenide manustamiseks | |
FR2796287B1 (fr) | Dispositif d'administration de medicament | |
AU2001258442A1 (en) | Drug delivery device, especially for the delivery of levonorgestrel | |
HK1043944A1 (en) | A novel drug delivery system: formulation for fat-soluble drugs. | |
EP1438087A4 (en) | SYSTEM FOR THE ADMINISTRATION OF A MEDICAMENTAL DELIVERY DEVICE |